| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/12/2000 | EP1017854A1 Documentation means for repertoires of nkr immunoreceptors and/or activatory or non-inhibitory immunoreceptor counterparts of nkr immnunoreceptors |
| 07/12/2000 | EP1017846A1 Control of immune responses by modulating activity of glycosyltransferases |
| 07/12/2000 | EP1017810A1 Agonist and antagonist peptides of carcinoembryonic antigen (cea) |
| 07/12/2000 | EP1017808A2 53bp2 complexes |
| 07/12/2000 | EP1017806A2 Compositions and methods for conferring tick immunity and preventing tick borne diseases |
| 07/12/2000 | EP1017723A2 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
| 07/12/2000 | EP1017721A1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
| 07/12/2000 | EP1017715A2 Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest |
| 07/12/2000 | EP1017713A1 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS |
| 07/12/2000 | EP1017707A1 29 human secreted proteins |
| 07/12/2000 | EP1017697A1 MODULES OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 07/12/2000 | EP1017678A1 1,5-diphenylpyrazole derivatives |
| 07/12/2000 | EP1017673A1 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents |
| 07/12/2000 | EP1017667A1 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 07/12/2000 | EP1017664A1 C3a receptor ligands |
| 07/12/2000 | EP1017418A1 Vaccine composition for preventing or treating c hepatitis |
| 07/12/2000 | EP1017407A2 Useful properties of human lactoferrin and variants thereof |
| 07/12/2000 | EP1017402A1 Control of acidic gut syndrome |
| 07/12/2000 | EP1017385A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1 |
| 07/12/2000 | EP1017378A1 Amide derivatives for the treatment of diseases mediated by cytokines |
| 07/12/2000 | EP1017353A2 Therapeutic process for inhibiting nf-kappa b |
| 07/12/2000 | EP1017283A1 Polynucleotide vaccine formulations |
| 07/12/2000 | EP0745073B1 5-substituted derivatives of mycophenolic acid |
| 07/12/2000 | EP0680336B1 Monoclonal anti-lfa-1 antibodies for the preparation of a medicament intended to prevent the rejection of organ transplants |
| 07/12/2000 | EP0642342B1 Selective cell inactivation in blood |
| 07/12/2000 | EP0613468B1 Substituted salicylic acids for the treatment of autoimmune diseases |
| 07/12/2000 | EP0610345B1 Combined cellular and immunosuppressive therapies |
| 07/12/2000 | EP0413762B1 Peptide analogs and their use as haptens to elicit catalytic antibodies |
| 07/12/2000 | CN1259960A Vaccine compositions comprising the helicobacter pylori FlgE polypeptide |
| 07/12/2000 | CN1259958A Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 07/12/2000 | CN1259951A Novel pharmaceutically useful compounds |
| 07/12/2000 | CN1259950A Pyrrolo [2,3D] pyrimidines and their use as tyrosine kinase inhibitors |
| 07/12/2000 | CN1259948A 6,7-disubstituted-4-aminopyrido [2,3-D] pyrimidine compounds |
| 07/12/2000 | CN1259940A Crystalline roxifiban |
| 07/12/2000 | CN1259873A Bio-pharmaceutical prepn. contg. live culture of bacillus and method treating viral and bacterial infection as well as immuno-deficiency conditions |
| 07/12/2000 | CN1259864A Rapamycin formulations for oral administration |
| 07/12/2000 | CN1054374C New (thia) cycloalkyl [b] indole compounds process for the prepn. thereof and pharmaceutical compositions containing them |
| 07/11/2000 | US6087505 Benzo[1,2-G]-chrom-3-ene, and benzo[1,2-G]-thiochrom-3-ene derivatives |
| 07/11/2000 | US6087392 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 07/11/2000 | US6087381 Pyrazole derivatives as p38 kinase inhibitors |
| 07/11/2000 | US6087336 Peptide derivatives useful in treating autoimmune diseases |
| 07/11/2000 | US6087330 Process to inhibit binding of the integrin α4 β1 to VCAM-1 or fibronectin and cyclic peptides therefor |
| 07/11/2000 | US6087169 HKABY60: polynucleotide encoding a helix-loop-helix ubiquitous kinase family polypeptide |
| 07/11/2000 | US6087150 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
| 07/11/2000 | US6087142 Valyl tRNA synthetase from streptococcus pneumoniae |
| 07/11/2000 | US6087122 Polynucleotide sequence which codes a mammalian polypeptide synthetases; for diagnosis, evaluation, prevention, and treatment of physiological defects |
| 07/11/2000 | US6086901 Imunological adjuvants and antigen entrapment |
| 07/11/2000 | US6086899 Ethylene oxide-propylene oxide copolymer |
| 07/11/2000 | US6086898 Administering listeria adjuvants and antigens for immunology |
| 07/11/2000 | US6086897 Isolation peptide from a protein allergen of dermatophagoide |
| 07/11/2000 | US6086894 Recombinant vaccine for diseases caused by encapsulated organisms |
| 07/11/2000 | US6086891 Plasmids |
| 07/11/2000 | US6086881 Spatially aligned conjugated composition having a thioether bond linkage |
| 07/11/2000 | US6086875 Receptor specific transepithelial transport of immunogens |
| 07/11/2000 | US6086873 Irradiating an antibody with ultraviolet light to expose a reactive sulfhydryl of the antibody without changing its biological function, administering to a host to generate a greater immune response than against the native antibody |
| 07/11/2000 | CA2162600C Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions |
| 07/11/2000 | CA2023340C (quinolin-2-ylmethoxy) indoles as inhibitors of the biosynthesis of leukotrienes |
| 07/06/2000 | WO2000039588A1 Detection of preactivated phagocytes |
| 07/06/2000 | WO2000039327A1 Peptidoglycan recognition proteins |
| 07/06/2000 | WO2000039308A1 Ikk3 kinase |
| 07/06/2000 | WO2000039304A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 07/06/2000 | WO2000039303A2 Modified hiv env polypeptides |
| 07/06/2000 | WO2000039302A2 Improved expression of hiv polypeptides and production of virus-like particles |
| 07/06/2000 | WO2000039279A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 07/06/2000 | WO2000039160A2 Caspase-8 interacting proteins |
| 07/06/2000 | WO2000039159A1 Superantigens |
| 07/06/2000 | WO2000039136A2 Human brainiac-5 |
| 07/06/2000 | WO2000039129A1 Immunosuppressive effects of pteridine derivatives |
| 07/06/2000 | WO2000039126A1 Method for preparing (r)- (+) -3 {1- [2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl}-1,1- dimethylurea, its salts solvates and/or hydrates |
| 07/06/2000 | WO2000039116A1 Aminopyrazole derivatives |
| 07/06/2000 | WO2000039101A1 Pyrimidine compounds |
| 07/06/2000 | WO2000039091A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/06/2000 | WO2000039089A1 3-azabicyclo[3.1.0.] hexane derivatives as opiate receptors ligands |
| 07/06/2000 | WO2000039081A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/06/2000 | WO2000039070A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | WO2000038785A2 Methods for treating certain diseases using naaladase inhibitors |
| 07/06/2000 | WO2000038713A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 07/06/2000 | WO2000038708A1 Treatment and prevention of immune rejection reactions |
| 07/06/2000 | WO2000038706A2 Methods for treating cancer and for mediating chemotaxis of dendritic cells |
| 07/06/2000 | WO2000038696A1 Cyanocobalamin (vitamin b12) treatment in allergic disease |
| 07/06/2000 | WO2000038655A1 Dosage forms comprising porous particles |
| 07/06/2000 | WO2000038623A1 Cosmetic or medical preparation for topical use |
| 07/06/2000 | WO2000038515A1 Peptide mimics useful for treating disease |
| 07/06/2000 | WO2000024899A3 Interleukin-1 homolog zil1a4 |
| 07/06/2000 | WO2000021988A3 Human ankyrin family protein |
| 07/06/2000 | WO2000021512A3 Composition and method for treating allergic diseases |
| 07/06/2000 | WO2000020612A3 Therapeutically active proteins in plants |
| 07/06/2000 | WO2000017222A8 31 human secreted proteins |
| 07/06/2000 | WO2000015770A3 Human serine/threonine protein kinases |
| 07/06/2000 | WO2000013703A3 Methods of treating hypertension and compositions for use therein |
| 07/06/2000 | WO2000009102A3 Carboxylic acids and isosteres of n-heterocyclic compounds for vision and memory disorders |
| 07/06/2000 | WO1999065516A9 Methods and compositions for treating diseases mediated by transglutaminase activity |
| 07/06/2000 | WO1999052514A3 Pharmaceutical composition and combination preparation for immunosuppressive therapy |
| 07/06/2000 | CA2621097A1 Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions |
| 07/06/2000 | CA2358687A1 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 07/06/2000 | CA2358385A1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 07/06/2000 | CA2358315A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | CA2356755A1 Superantigens |
| 07/06/2000 | CA2356661A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 07/06/2000 | CA2356548A1 Human brainiac-5 |